Circulating tumor DNA analysis:from discovery to clinical practice
10.3760/cma.j.issn.1009-9158.2020.02.001
- VernacularTitle: 循环肿瘤DNA检测——从发现到临床
- Author:
Rui ZHANG
1
;
Jinming LI
Author Information
1. National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Engineering Research Center of Laboratory Medicine, Beijing 100730, China
- Publication Type:Editorial
- Keywords:
Circulating tumor DNA;
Clinical laboratory techniques;
Biomarkers
- From:
Chinese Journal of Laboratory Medicine
2020;43(2):101-104
- CountryChina
- Language:Chinese
-
Abstract:
Circulating tumor DNA analysis is the focused issue in clinical research. A few of biomarkers have been used in clinical practice, while some are in the discovery phase. The key challenges for clinical laboratories on the way from discovery to clinical practice of the circulating tumor DNA analysis, including choosing the intended use based on evidence for clinical validity and utility, quality assurance for the testing process, reporting and interpretation for the results will be discussed.
